95. Autoimmune hepatitis Clinical trials / Disease details

Clinical trials : 52 / Drugs : 68 - (DrugBank : 27) / Drug target genes : 18 - Drug target pathways : 111

1 trial found

diseases per page:

Showing 1 to 1 of 1 diseases

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT04129489 (ClinicalTrials.gov)	February 7, 2019	18/3/2019	A Phase 2a Study to Evaluate the Safety and Efficacy of CannabidiolOnly as Maintenance Therapy and S ...	A Phase 2a Open Label, Single Arm Study to Evaluate the Safety and Efficacy of CannabidiolOnly as Ma ...	Autoimmune Hepatitis	Drug: Cannabidiol	Stero Biotechs Ltd.	NULL	Terminated	18 Years	N/A	All	2	Phase 2	Israel